Renaissance Technologies - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 95 filers reported holding OVID THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$310
-17.6%
80,800
-29.6%
0.00%0.0%
Q2 2023$376
+20.9%
114,700
-4.9%
0.00%
Q1 2023$311
+39.5%
120,600
+0.7%
0.00%
Q4 2022$223
-99.9%
119,800
+0.8%
0.00%
Q3 2022$219,000
-17.7%
118,800
-4.0%
0.00%
Q2 2022$266,0000.0%123,800
+46.0%
0.00%
Q1 2022$266,000
+41.5%
84,800
+44.7%
0.00%
Q4 2021$188,000
+62.1%
58,600
+69.9%
0.00%
Q3 2021$116,000
-92.9%
34,500
-95.1%
0.00%
-100.0%
Q4 2020$1,641,000
-64.3%
710,507
+13.8%
0.00%
-50.0%
Q2 2020$4,600,000
+81.0%
624,109
-26.8%
0.00%
+100.0%
Q1 2020$2,541,000
-43.6%
852,843
-21.4%
0.00%
-33.3%
Q4 2019$4,502,000
+136.8%
1,084,709
+84.9%
0.00%
+50.0%
Q3 2019$1,901,000
+118.0%
586,725
+24.4%
0.00%
+100.0%
Q2 2019$872,000
+35.6%
471,609
+29.8%
0.00%0.0%
Q1 2019$643,000
+383.5%
363,217
+559.2%
0.00%
Q4 2018$133,00055,1000.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,006,185$12,860,0005.90%
GLOBEFLEX CAPITAL L P 2,794,834$8,972,0000.92%
BVF INC/IL 6,631,051$21,286,0000.77%
EcoR1 Capital, LLC 6,082,200$19,524,0000.62%
CHI Advisors LLC 400,000$1,284,0000.43%
Ikarian Capital, LLC 705,082$2,264,0000.34%
Artal Group S.A. 2,500,000$8,025,0000.22%
DCF Advisers, LLC 141,701$455,0000.18%
PLATINUM INVESTMENT MANAGEMENT LTD 766,901$2,462,0000.07%
ACADIAN ASSET MANAGEMENT LLC 2,040,084$6,543,0000.02%
View complete list of OVID THERAPEUTICS INC shareholders